Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Diertine
2. Dihydroergocristine
3. Dihydroergocristine Monomesylate
4. Enirant
5. Ergodavur
6. Mesylate, Dihydroergocristine
7. Monomesylate, Dihydroergocristine
1. 24730-10-7
2. Dihydroergocristinmesilat
3. Dihydroergocristine Mesilate
4. 9,10-dihydroergocristine Methanesulfonate
5. Dihydroergocristine Methanesulfonate
6. Mls000069354
7. Ds7cl18uam
8. Smr000058240
9. Chebi:31490
10. (6ar,9r,10ar)-n-[(1s,2s,4r,7s)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic Acid
11. 5'alpha-benzyl-9,10alpha-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione Monomethanesulphonate
12. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha,10alpha)-, Methanesulfonate (1:1)
13. Dihydroergocristine (mesylate)
14. Unii-ds7cl18uam
15. Sr-01000075381
16. Dihydroergocristinmesilat [german]
17. Diertine (tn)
18. Prestwick_745
19. Einecs 246-434-6
20. Dihydroergocristine Methanesulfonate Salt
21. Ergocristine, Dihydro-, Methanesulfonate
22. Oxamide Methanesulfonate
23. Opera_id_1422
24. Mls001076298
25. Mls001333686
26. Mls002222256
27. Schembl178144
28. Dihydroergocristine Monomesylate
29. Cid_444034
30. Chembl1255837
31. Bdbm30706
32. Dtxsid20872322
33. Ergocristine, 9,10-dihydro-, Monomethanesulfonate (salt)
34. 9,10-dihydroergocristine Mesilate
35. 9,10-dihydroergocristine Mesylate
36. C35h41n5o5.ch3so3h
37. Hms1569b06
38. Hms2096b06
39. Hms2233k22
40. Hms3411o07
41. Hms3675o07
42. Dihydroergocristine Mesilate (ban)
43. Hy-n2319
44. Mfcd00153792
45. Akos024458318
46. Ccg-208194
47. Ncgc00025380-03
48. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'.alpha.,10.alpha.)-, Monomethanesulfonate (salt)
49. Ergotamane-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'-alpha,10-alpha)-, Monomethanesulfonate (salt)
50. Dihydroergocristine Mesilate [mart.]
51. Dihydroergocristine Mesylate [vandf]
52. Cs-0020631
53. D-155
54. Dihydroergocristine Mesilate [who-dd]
55. Eu-0100409
56. Mls000069354-02
57. D07833
58. Dihydroergocristine Methanesulfonate [mi]
59. 9,10-dihydroergocristine Methanesulphonate
60. Dihydroergocristine Mesilate [ep Monograph]
61. Sr-01000000009
62. J-015650
63. Sr-01000000009-2
64. Sr-01000075381-1
65. Q27114325
66. Dihydroergocristine Mesilate, European Pharmacopoeia (ep) Reference Standard
67. (10alphah)-5'alpha-benzyl-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)-9,10-dihydroergotaman Methanesulfonate
68. (5'?,10?)-9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-trione Mesylate
69. (5'alpha,10alpha)-9,10-dihydro-12'-hydroxy-2'-(1 -methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-tr Ione Mesylate
70. (6ar,9r,10ar)-n-((2r,5s,10as,10bs)-5-benzyl-10b-hydroxy-2-isopropyl-3,6-dioxooctahydro-2h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carb
71. (6ar,9r,10ar)-n-((2r,5s,10as,10bs)-5-benzyl-10b-hydroxy-2-isopropyl-3,6-dioxooctahydro-2h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide Methanesulfonate
72. (6ar,9r,10ar)-n-[(2r,5s,10as,10bs)-5-benzyl-10b-hydroxy-2-(1-methylethyl)-3,6-dioxo-octahydro-8h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
73. 5'.alpha.-benzyl-9,10.alpha.-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione Monomethanesulphonate
74. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'.alpha.,10.alpha.)-, Monomethanesulphonate (salt)
75. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha,10alpha)-, Monomethanesulfonate (salt)
Molecular Weight | 707.8 g/mol |
---|---|
Molecular Formula | C36H45N5O8S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 5 |
Exact Mass | 707.29888458 g/mol |
Monoisotopic Mass | 707.29888458 g/mol |
Topological Polar Surface Area | 181 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 1300 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Adrenergic Antagonists
Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE. (See all compounds classified as Adrenergic Antagonists.)
Related Excipient Companies